DGAP-News: Translational Research Institute Implements SGI Super Computing Solutions to Accelerate Cures for Cancer
(firmenpresse) - SGI
04.06.2013 22:15
---------------------------------------------------------------------------
BRISBANE, Australia, 2013-06-04 22:15 CEST (GLOBE NEWSWIRE) --
SGI (Nasdaq:SGI), the trusted leader in technical computing, today announced
that Translational Research Institute (TRI) has selected SGI to provide a big
data HPC solution powered by SGI(r) UV(tm) 2000 shared memory platform, SGI(r)
Rackable(r) clusters and SGI(r) InfiniteStorage(tm) to accelerate results at its new
state-of-the-art research centre.
This new facility, which represents four leading medical research institutes,
will focus on advanced treatments and therapies for common and serious disease
such as cancers, diabetes, inflammatory diseases, HIV, malaria, bone and joint
diseases and obesity. The Institute is destined to be the largest biomedical
research institute in the Southern Hemisphere.
Researchers will now have access to the necessary technology and facilities in
one location, which will positively impact productivity through the rate at
which work is processed and scientific results are achieved. SGI's compute and
data storage solution provides more than 2,200 SGI Rackable compute cores, 256
cores and 4TB of memory SGI UV 2000 and more than one petabyte of SGI
InfiniteStorage high performance storage. Up to three petabytes of historical
and inactive data will be stored on tape and available via SGI's DMF system.
The combination of SGI Rackable scale out clusters, UV 2000 shared memory for
large 'in memory' application requirements along with high performance storage
offered the flexibility of compute, storage platforms and software that TRI
needed to tackle their big data problems. This solution will complement the
massive amounts of data that high resolution gene sequencers, microscopes and
associated laboratory equipment generate. The SGI solution will assist in
increasing productivity and accelerating the time to discovery of new
treatments, subsequent commercialisation and significant patents.
TRI Chief Operating Officer Dr. Kate Johnston highlights the rapid advances
seen in research and development over the last decade, signalling that
scientific research is fast becoming an exercise in handling enormous data
sets.
'Scientists are essentially looking for the veritable 'needle in a haystack' in
amongst this data,' said Dr. Johnston. 'Without the correct technology to do
this it could take researchers years to find their 'needle.' The SGI High
Performance cluster provides our researchers with the computing power they need
in order to both analyse and appropriately store their large experimental
datasets.'
SGI has a long and positive reputation of providing high performance
infrastructure to enable Australian research projects. Dr. Eng Lim Goh, SGI's
senior vice president and chief technology officer, speaks about how important
it is for SGI to be a part of this pioneering work.
'The storage, analytical and computational needs of TRI are substantial and
unique,' said Dr. Goh. 'SGI with our big data solutions are proud to be a part
of TRI as they translate their discoveries to advances in patient care.'
TRI's collective expertise across common and serious diseases such as cancers,
diabetes, inflammatory diseases, HIV, malaria, bone and joint diseases, obesity
and children's health research will have a direct impact on improved public
health andenhanced preventative treatments for people worldwide. The Institute
brings four of Australia's leading research facilities together with the aim of
translating the findings of basic biomedical research into better patient
outcomes.
About SGI
SGI, the trusted leader in technical computing, is focused on helping customers
solve their most demanding business and technology challenges. Visit sgi.com
for more information.
Connect with SGI on Twitter ((at)sgi_corp), YouTube (youtube.com/sgicorp),
Facebook (facebook.com/sgiglobal) and LinkedIn.
About Translational Research Institute (TRI)
The Institute a joint venture between The University of Queensland Diamantina
Institute, Queensland University of Technology's Institute of Health and
Biomedical Innovation, Mater Research Institute and the Princess Alexandra
Hospital Centre's for Health Research has been made possible through funding
provided by the Australian and Queensland Governments, The Atlantic
Philanthropies, UQ and QUT.
Media Contacts:
Ellen Sinclair
Howorth
ellen(at)howorth.com.au
(c) 2013 Silicon Graphics International Corp. SGI, UV and the SGI logo are
trademarks or registered trademarks of Silicon Graphics International Corp. or
its subsidiaries in the United States and/or other countries. Intel and Xeon
are registered trademarks of Intel Corporation. All other trademarks are
property of their respective holders.
News Source: NASDAQ OMX
04.06.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: SGI
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US82706L1089
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
Datum: 04.06.2013 - 22:15 Uhr
Sprache: Deutsch
News-ID 266534
Anzahl Zeichen: 6656
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 310 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Translational Research Institute Implements SGI Super Computing Solutions to Accelerate Cures for Cancer"
steht unter der journalistisch-redaktionellen Verantwortung von
SGI (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).